President Biden offers another push on drug price savings via executive order
Building off his recently-signed legislation allowing Medicare to start negotiating prices in some limited circumstances for the most expensive pharmaceuticals, President Joe Biden today will sign an Executive Order directing HHS to consider what more it can do to drive down prescription drug costs.
Under the order, HHS will have three months to submit a formal report outlining how to use its “Innovation Center,” created by Obamacare, and other existing authorities to lower drug costs and promote access to innovative drugs for Medicare beneficiaries.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.